[go: up one dir, main page]

DE69920011D1 - Rekombinanter venezolanische-equine-pferdeenzephalitis-virusimpstoff - Google Patents

Rekombinanter venezolanische-equine-pferdeenzephalitis-virusimpstoff

Info

Publication number
DE69920011D1
DE69920011D1 DE69920011T DE69920011T DE69920011D1 DE 69920011 D1 DE69920011 D1 DE 69920011D1 DE 69920011 T DE69920011 T DE 69920011T DE 69920011 T DE69920011 T DE 69920011T DE 69920011 D1 DE69920011 D1 DE 69920011D1
Authority
DE
Germany
Prior art keywords
zephalitis
venezolanian
equine
vaccine
horse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69920011T
Other languages
English (en)
Other versions
DE69920011T2 (de
Inventor
Alice Marie Bennett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UK Secretary of State for Defence
Original Assignee
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UK Secretary of State for Defence filed Critical UK Secretary of State for Defence
Publication of DE69920011D1 publication Critical patent/DE69920011D1/de
Application granted granted Critical
Publication of DE69920011T2 publication Critical patent/DE69920011T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69920011T 1998-05-29 1999-05-05 Rekombinantes virus-vakzin gegen das virus der venezolanischen equinen encephalitis Expired - Lifetime DE69920011T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9811433 1998-05-29
GB9811433A GB2337755B (en) 1998-05-29 1998-05-29 Virus vaccine
PCT/GB1999/001387 WO1999063098A1 (en) 1998-05-29 1999-05-05 Recombinant venezuelan equine encephalitis virus vaccine

Publications (2)

Publication Number Publication Date
DE69920011D1 true DE69920011D1 (de) 2004-10-14
DE69920011T2 DE69920011T2 (de) 2005-09-15

Family

ID=10832820

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69920011T Expired - Lifetime DE69920011T2 (de) 1998-05-29 1999-05-05 Rekombinantes virus-vakzin gegen das virus der venezolanischen equinen encephalitis

Country Status (14)

Country Link
US (2) USRE41745E1 (de)
EP (1) EP1084261B8 (de)
AR (1) AR020080A1 (de)
AT (1) ATE275631T1 (de)
AU (1) AU3834999A (de)
BR (1) BR9910814A (de)
CA (1) CA2329133C (de)
DE (1) DE69920011T2 (de)
DK (1) DK1084261T3 (de)
ES (1) ES2224655T3 (de)
GB (1) GB2337755B (de)
MX (1) MXPA00011708A (de)
PT (1) PT1084261E (de)
WO (1) WO1999063098A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2337755B (en) 1998-05-29 2003-10-29 Secr Defence Virus vaccine
US8623379B2 (en) 2000-03-02 2014-01-07 Emory University Compositions and methods for generating an immune response
AU2002211948B2 (en) 2000-03-02 2007-09-13 Emory University DNA expression vectors and methods of use
CA2454959C (en) 2001-03-08 2018-07-10 Bernard Moss Mva expressing modified hiv envelope, gag, and pol genes
EP1528677B1 (de) * 2003-10-30 2006-05-10 Agilent Technologies, Inc. Akustisch gekoppelter Dünnschicht-Transformator mit zwei piezoelektrischen Elementen, welche entgegengesetzte C-Axen Orientierung besitzten
RU2275937C1 (ru) * 2004-10-19 2006-05-10 Вирусологический центр НИИ Микробиологии Министерства обороны Российской Федерации Способ презентации вирусных антигенов иммунной системе хозяина, основанный на протеасомоопосредованной технологии, предназначенный для разработки методов биологической защиты
WO2008101349A1 (en) * 2007-02-23 2008-08-28 Her Majesty The Queen, In Right Of Canada, As Repesented By The Minister Of National Defence Recombinant viral vectors for prevention and protection against alphavirus infection
WO2010142017A1 (en) 2009-06-09 2010-12-16 Defyrus, Inc . Administration of interferon for prophylaxis against or treatment of pathogenic infection
EA201391183A1 (ru) 2011-02-15 2014-02-28 Иммьюн Дизайн Корп. Способы усиления иммуногенспецифических иммунных ответов при помощи векторных вакцин
MX350795B (es) 2011-04-08 2017-09-19 Inmune Design Corp Composiciones inmunogenicas y metodos para utilizar las composiciones para inducir respuestas inmunes humorales y celulares.
US9555090B2 (en) 2012-04-04 2017-01-31 The United States of America as repesented by the Secretary of Army, on behalf of the U.S. Army Medical Research Institute of Infections Diseases Equine encephalitis virus vaccines and methods of using thereof
DK2850431T3 (en) 2012-05-16 2018-07-16 Immune Design Corp Vaccines against HSV-2
EP3939423B1 (de) * 2012-11-05 2024-03-06 Regeneron Pharmaceuticals, Inc. Genetisch modifizierte nagetiere und verfahren zur verwendung davon
ES2738582T3 (es) 2014-02-14 2020-01-23 Immune Design Corp Inmunoterapia del cáncer a través de combinación de inmunoestimulación local y sistémica
US20170196954A1 (en) 2014-07-15 2017-07-13 Immune Design Corp. Prime-boost regimens with a tlr4 agonist adjuvant and a lentiviral vector
WO2017129765A1 (en) 2016-01-29 2017-08-03 Bavarian Nordic A/S Recombinant modified vaccinia virus ankara (mva) equine encephalitis virus vaccine
KR102536850B1 (ko) 2016-04-15 2023-05-26 알파인 이뮨 사이언시즈, 인코포레이티드 Icos 리간드 변이체 면역조절 단백질 및 그의 용도
IL262366B2 (en) 2016-04-15 2024-07-01 Alpine Immune Sciences Inc Cd80 variant immunomodulatory proteins and uses thereof
US11471488B2 (en) 2016-07-28 2022-10-18 Alpine Immune Sciences, Inc. CD155 variant immunomodulatory proteins and uses thereof
EP3491013A1 (de) 2016-07-28 2019-06-05 Alpine Immune Sciences, Inc. Cd155-variante immunmodulatorische proteine und verwendungen davon
WO2018022945A1 (en) 2016-07-28 2018-02-01 Alpine Immune Sciences, Inc. Cd112 variant immunomodulatory proteins and uses thereof
CN119161451A (zh) 2017-03-16 2024-12-20 高山免疫科学股份有限公司 Pd-l1变体免疫调节蛋白及其用途
CA3054068A1 (en) 2017-03-16 2018-09-20 Alpine Immune Sciences, Inc. Cd80 variant immunomodulatory proteins and uses thereof
JP2020511144A (ja) 2017-03-16 2020-04-16 アルパイン イミューン サイエンシズ インコーポレイテッド Ｐｄ−ｌ２バリアント免疫調節タンパク質及びその使用
CA3057171A1 (en) 2017-03-30 2018-10-04 The University Of Queensland Chimeric polypeptides containing virus fusion ectodomain and complementary heptad repeats and uses thereof
EP4400174A3 (de) 2017-09-01 2024-10-23 The Francis Crick Institute Limited Immunregulierende moleküle und deren verwendungen
KR102813968B1 (ko) 2017-10-10 2025-05-29 알파인 이뮨 사이언시즈, 인코포레이티드 Ctla-4 변이체 면역조절 단백질 및 이의 용도
AU2018351000B2 (en) 2017-10-18 2023-11-30 Alpine Immune Sciences, Inc. Variant ICOS Ligand immunomodulatory proteins and related compositions and methods
CA3087149A1 (en) 2018-01-03 2019-07-11 Alpine Immune Sciences, Inc. Multi-domain immunomodulatory proteins and methods of use thereof
US12065476B2 (en) 2018-06-15 2024-08-20 Alpine Immune Sciences, Inc. PD-1 variant immunomodulatory proteins and uses thereof
US20220177587A1 (en) 2018-09-19 2022-06-09 Alpine Immune Sciences, Inc. Methods and uses of variant cd80 fusion proteins and related constructs
CA3120868A1 (en) 2018-11-30 2020-06-04 Alpine Immune Sciences, Inc. Cd86 variant immunomodulatory proteins and uses thereof
EP4438054A3 (de) 2019-04-17 2025-01-08 Alpine Immune Sciences, Inc. Verfahren und verwendungen von icos-ligandenvarianten (icosl)-fusionsproteinen
CN117736297A (zh) 2020-05-08 2024-03-22 高山免疫科学股份有限公司 April和baff抑制性免疫调节蛋白及其使用方法
EP4333869A1 (de) 2021-05-07 2024-03-13 Alpine Immune Sciences, Inc. Verfahren zur dosierung und behandlung mit einem taci-fc-fusionsimmunmodulatorischen protein
EP4490173A1 (de) 2022-03-07 2025-01-15 Alpine Immune Sciences, Inc. Immunmodulatorische proteine aus cd80-polypeptidvarianten, zelltherapien davon sowie zugehörige verfahren und verwendungen
JP2025535041A (ja) 2022-10-04 2025-10-22 アルパイン イミューン サイエンシズ インコーポレイテッド 自己抗体介在疾患の治療における使用のための変異ｔａｃｉ－ｆｃ融合タンパク質

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185440A (en) * 1989-06-20 1993-02-09 North Carolina State University cDNA clone coding for Venezuelan equine encephalitis virus and attenuating mutations thereof
US5505947A (en) * 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
US6261570B1 (en) * 1997-05-20 2001-07-17 The United States Of America As Represented By The Secretary Of The Army Live attenuated virus vaccines for western equine encephalitis virus, eastern equine encephalitis virus, and venezuelan equine encephalitis virus IE and IIIA variants
GB2337755B (en) 1998-05-29 2003-10-29 Secr Defence Virus vaccine

Also Published As

Publication number Publication date
ATE275631T1 (de) 2004-09-15
GB2337755A (en) 1999-12-01
US6936257B1 (en) 2005-08-30
DK1084261T3 (da) 2005-01-17
BR9910814A (pt) 2001-02-13
WO1999063098A1 (en) 1999-12-09
USRE41745E1 (en) 2010-09-21
CA2329133C (en) 2011-07-12
AR020080A1 (es) 2002-04-10
MXPA00011708A (es) 2005-10-13
PT1084261E (pt) 2005-01-31
CA2329133A1 (en) 1999-12-09
GB2337755B (en) 2003-10-29
GB9811433D0 (en) 1998-07-22
EP1084261A1 (de) 2001-03-21
AU3834999A (en) 1999-12-20
EP1084261B8 (de) 2004-12-15
DE69920011T2 (de) 2005-09-15
ES2224655T3 (es) 2005-03-01
EP1084261B1 (de) 2004-09-08

Similar Documents

Publication Publication Date Title
DE69920011D1 (de) Rekombinanter venezolanische-equine-pferdeenzephalitis-virusimpstoff
NO2010013I1 (no) Rekombinant FSH-CTP
NO982097D0 (no) Peptider
NO982098L (no) Peptider
DE59914158D1 (de) Metallocenmonohalogenide
ATE341990T1 (de) Sigmidoskop
DE59912371D1 (de) Gleitschalungsfertiger
DE59902874D1 (de) Buchsenkontakt
DE59901560D1 (de) Retrograder tibianagel
DE59907306D1 (de) Fadenchangierung
DE59906931D1 (de) Exzenterzahnradgetriebe
DE59911683D1 (de) Fahrzeugschliessanlage
DE69933647D1 (de) Rekombinante lysophosphatidsäure - phosphatase.
DE59903966D1 (de) Exzenterzahnradgetriebe
ATE262513T1 (de) Benzoylpyridazine
DE59913393D1 (de) Fadenchangierung
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
DE59908057D1 (de) Underdruckhandhabungseinrichung
FR2791348B1 (fr) POLYPEPTIDE Npt2B
DE59808995D1 (de) Endomikroskopsystem
DE59807217D1 (de) Nadellager
DK0862850T3 (da) Mejetærsker
DE19842103B4 (de) Stanznietzuführung
DE59900612D1 (de) Dispersionsazofarbstoffmischungen

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: THE SECRETARY OF STATE FOR DEFENCE, SALISBURY, GB

8364 No opposition during term of opposition